|
|
Volumn 1, Issue 1, 2001, Pages 1-2
|
|
Pediatric leukemia in the new millennium
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CLADRIBINE;
CYTOCHROME P450;
CYTOSTATIC AGENT;
DAUNORUBICIN;
DEXAMETHASONE;
GEMTUZUMAB OZOGAMICIN;
GLUCOCORTICOID;
GLUTATHIONE TRANSFERASE;
IMATINIB;
LIPOSOME;
METHOTREXATE;
PREDNISOLONE;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
PROTEIN TYROSINE KINASE INHIBITOR;
THIOPURINE METHYLTRANSFERASE;
TRIMETREXATE;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
CANCER MORTALITY;
CANCER SURVIVAL;
CHILD;
CHILDHOOD LEUKEMIA;
COST EFFECTIVENESS ANALYSIS;
DEVELOPED COUNTRY;
DRUG USE;
EDITORIAL;
GENETIC POLYMORPHISM;
HEALTH CARE QUALITY;
HEART DISEASE;
HUMAN;
INDIVIDUALIZATION;
PATIENT CARE;
PHARMACOGENOMICS;
PRESCRIPTION;
PROGNOSIS;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
|
EID: 0035559803
PISSN: 14737140
EISSN: None
Source Type: Journal
DOI: 10.1586/14737140.1.1.1 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
